SeekingAlpha · Sep 19, 2026
Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher
Henry Schein remains a dominant global provider of dental and medical practitioner supplies. Find out why HSIC stock is a buy.

NASDAQ · HSIC
Healthcare · Medical - Distribution
$87.43
Down-$2.38 (-2.72%)
Updated Sep 23, 2026, 10:05 PM
SID Score
5.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
HSIC closed at $87.43 after 20 trading sessions, down 2.48% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $85.93 | $87.64 | $85.58 | $87.43 | 1.07M |
| Sep 21, 2026 | $85.25 | $85.80 | $84.40 | $85.20 | 1.35M |
| Sep 18, 2026 | $84.84 | $85.96 | $84.41 | $84.84 | 2.22M |
| Sep 17, 2026 | $87.01 | $87.10 | $84.15 | $85.04 | 1.8M |
| Sep 16, 2026 | $87.52 | $88.32 | $86.44 | $86.77 | 1.02M |
| Sep 15, 2026 | $88.93 | $88.93 | $87.26 | $87.52 | 1.55M |
| Sep 14, 2026 | $88.57 | $89.115 | $87.645 | $88.93 | 818.39K |
| Sep 11, 2026 | $88.54 | $88.79 | $87.36 | $88.36 | 713.85K |
| Sep 10, 2026 | $88.20 | $88.22 | $87.11 | $87.30 | 1.54M |
| Sep 9, 2026 | $88.14 | $88.92 | $87.65 | $87.97 | 768.11K |
| Sep 8, 2026 | $89.50 | $89.99 | $88.7101 | $88.86 | 711.85K |
| Sep 4, 2026 | $89.91 | $90.54 | $89.645 | $89.81 | 887.87K |
| Sep 3, 2026 | $90.68 | $91.69 | $89.56 | $90.86 | 679.34K |
| Sep 2, 2026 | $89.02 | $91.36 | $88.605 | $90.39 | 859.39K |
| Sep 1, 2026 | $89.80 | $90.15 | $88.00 | $88.52 | 718.25K |
| Aug 31, 2026 | $88.93 | $90.00 | $88.1638 | $89.80 | 1.15M |
| Aug 28, 2026 | $90.54 | $91.09 | $89.47 | $89.52 | 795.97K |
| Aug 27, 2026 | $90.30 | $91.39 | $89.605 | $90.28 | 784.93K |
| Aug 26, 2026 | $89.97 | $90.67 | $89.49 | $90.38 | 697.17K |
| Aug 25, 2026 | $89.19 | $89.84 | $88.74 | $89.65 | 819.51K |
The latest Smart Investors Daily articles mentioning HSIC.
HSIC research
Company profile and research snapshot.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| Aug 5, 2026 | Citigroup | Buy | — |
| Aug 5, 2026 | UBS | Neutral | — |
| Aug 5, 2026 | BTIG | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 19, 2026
Henry Schein remains a dominant global provider of dental and medical practitioner supplies. Find out why HSIC stock is a buy.
Yahoo · Sep 18, 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Yahoo · Sep 16, 2026
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Yahoo · Sep 16, 2026
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HSIC.